Blog
RSS FeedPosted by Michael Wonder on 10 Jan 2017
Australian approval for drug that 'melts' leukaemia
10 January 2017 - A new anti-cancer drug with the power to ‘melt away’ certain advanced forms of chronic lymphocytic ...
Posted by Michael Wonder on 22 Dec 2016
TGA approves new lung cancer drug osimertinib for patients dealt cruel double blow
23 December 2016 - Elly Calabia doesn't talk about survival rates and life expectancy with her oncologist. ...
Posted by Michael Wonder on 20 Dec 2016
TGA approves new uses for Janssen's Imbruvica
20 December 2016 - The TGA has approved the use of ibrutinib for first-line use in patients with chronic lymphocytic ...
Posted by Michael Wonder on 06 Dec 2016
Antizol approved by TGA
5 December 2016 - The TGA has approved a new medicine from AFT Pharmaceuticals. ...
Posted by Michael Wonder on 05 Dec 2016
Nocdurna approved by TGA
5 December 2016 - The TGA has approved a new indication for Ferring's desmopressin acetate. ...
Posted by Michael Wonder on 05 Dec 2016
TGA approves AbbVie's Technivie
5 December 2016 - The TGA has approved another AbbVie combination product for use by patients with chronic hepatitis C ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves extended use of Harvoni
23 November 2016 - The TGÅ has approved the use of Harvoni in additional genotypes. ...
Posted by Michael Wonder on 23 Nov 2016
Belsomra finally approved by TGA
23 November 2016 - The TGA has approved MSD's orexin receptor antagonist. ...
Posted by Michael Wonder on 23 Nov 2016
Halaven cleared by TGA for sarcoma
23 November 2016 - Eisai bags a second use for its halichondrin B analogue. ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves another Opdivo for another cancer type
23 November 2016 - The TGA has sanctioned the use of nivolumab for use by patients with renal cell carcinoma. ...
Posted by Michael Wonder on 20 Nov 2016
TGA approves Grifols' Prolastin C
17 November 2016 - The TGA has approved Grifols' new alfa-1-proteinase inhibitor. ...
Posted by Michael Wonder on 17 Nov 2016
TGA approves Ninlaro
17 November 2016 - The TGA has approved Takeda's proteasome inhibitor for use by patients with multiple myeloma. ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves new combination product for type 2 diabetes
31 October 2016 - The TGA has approved AstraZeneca's Qtern (saxagliptin hydrochloride with dapagliflozin propanediol monohydrate). ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves yet another use for Humira (adalimumab)
31 October 2016 - AbbVie clocks up another indication for its TNF-alfa inhibitor. ...
Posted by Michael Wonder on 30 Sep 2016
Fast-track approval of medicines in Australia
30 September 2016 - The Australian Government has recently taken steps to fast track the registration of new medicines, generics, and ...